attenuation parameter - List of Frontiers' open access articles
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases - Incacare
flowCAST-Basophils-Surrogate-Marker - Buhlmann Diagnostics Corp
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
![PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ae9f320037de4f081b4772e3245508f1d8bc6b3/3-Figure1-1.png "PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar")
PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar
Optimized sensitive and inexpensive method to measure D-lactate as a surrogate marker of methylglyoxal fluxes in metabolically relevant contexts - ScienceDirect
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | GeroScience
Surrogate Endpoints | Evidera
Diagnostics | Free Full-Text | Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Surrogate Endpoint | Definitive Healthcare
Surrogate Endpoints | Evidera
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework | Nature Reviews Drug Discovery
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - ScienceDirect
Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books
Example 1: Continuous Surrogate Marker • OptimalSurrogate
Surrogate Endpoints and Biomarkers | Basicmedical Key
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
Surrogate Markers of Chronic Allograft Nephropathy in Man - ppt download
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Proteomics of Hepatocellular Carcinoma: Serum Vimentin As a Surrogate Marker for Small Tumors (≤2 cm) | Journal of Proteome Research
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013
